<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004191A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004191</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13919499</doc-number><date>20130617</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>24</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>20</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>209</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>2081</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>424465</main-classification></classification-national><invention-title id="d0e43">MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12639664</doc-number><date>20091216</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8486449</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13919499</doc-number></document-id></child-doc></relation></continuation><us-provisional-application><document-id><country>US</country><doc-number>61138092</doc-number><date>20081216</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Paladin Labs Inc.</orgname><address><city>Montreal</city><country>CA</country></address></addressbook><residence><country>CA</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Paladin Labs Europe Limited</orgname><address><city>Dublin</city><country>IE</country></address></addressbook><residence><country>IE</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Paladin Labs (Barbados) Inc.</orgname><address><city>Hastings</city><country>BB</country></address></addressbook><residence><country>BB</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Rahmouni</last-name><first-name>Miloud</first-name><address><city>Pierrefonds</city><country>CA</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Gervais</last-name><first-name>Sonia</first-name><address><city>Laval</city><country>CA</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Sant</last-name><first-name>Vinayak</first-name><address><city>Pittsburgh</city><state>PA</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Smith</last-name><first-name>Damon</first-name><address><city>Saint-Laurent</city><country>CA</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Duffayet</last-name><first-name>Frederic</first-name><address><city>Montreal</city><country>CA</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>Rustom</last-name><first-name>Shams</first-name><address><city>Saint-Laurent</city><country>CA</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>El-Jammal</last-name><first-name>Ali</first-name><address><city>Montreal</city><country>CA</country></address></addressbook></inventor><inventor sequence="07" designation="us-only"><addressbook><last-name>Ndong</last-name><first-name>Jean-Michel</first-name><address><city>Repentigny</city><country>CA</country></address></addressbook></inventor><inventor sequence="08" designation="us-only"><addressbook><last-name>Bichara</last-name><first-name>Ali</first-name><address><city>Montreal</city><country>CA</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>PALADIN LABS INC.</orgname><role>03</role><address><city>Montreal</city><state>QC</state><country>CA</country></address></addressbook></assignee><assignee><addressbook><orgname>PALADIN LABS EUROPE LIMITED</orgname><role>03</role><address><city>Dublin</city><country>IE</country></address></addressbook></assignee><assignee><addressbook><orgname>PALADIN LABS (BARBADOS) INC.</orgname><role>03</role><address><city>Hastings, Christ Church</city><country>BB</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Disclosed is a misuse preventative, controlled release composition in the form of a multilayered oral dosage form. A first layer contains a plurality of controlled release microparticles having a pharmaceutically active agent (for example, an opioid analgesic) disposed therein. A second layer comprises a pharmaceutically active agent that can be the same or different from the pharmaceutically active agent in the microparticles. The composition further comprises a superabsorbent material disposed within the first layer, the second layer, or both the first layer and the second layer. When crushed, either intentionally or accidentally, and exposed to an aqueous medium, the superabsorbent material swells to encapsulate the microparticles, which remain substantially intact thereby retarding the release of the pharmaceutically active agent from the composition.</p></abstract></us-patent-application>